Abstract: The present invention provides a recombinant fusion protein comprising an antigenic amino acid sequence fused to at least a portion of the gpX glycoprotein from pseudorabies virus. Such a protein may be formulated into a vaccine and delivered to an animal using a live herpesvirus vector adapted to express the fusion protein.
Type:
Grant
Filed:
July 27, 1988
Date of Patent:
June 29, 1993
Assignee:
Prutech Research And Development
Inventors:
Mark D. Cochran, Christina H. Chiang, Richard D. MacDonald